abstract |
The present invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell proliferation disorders and cancers, having the Formula: (see Formula) where A, U, W1, W2 , W3, R1-R6, and R9 are described herein. |